RNAi 治疗市场战略、顶尖参与者、增长机会、2031 年分析和预测

  • Report Code : TIPRE00007157
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2021 年 RNAi 治疗市场价值为 15 亿美元,预计到 2031 年将达到 32 亿美元。预计 2023 年至 2031 年期间市场复合年增长率为 16.5%。不断增长的研发 (R&D) 活动可能仍是 RNAi 治疗市场的主要趋势。

 

RNAi 治疗市场分析

 

RNAi 疗法在癌症治疗中的应用

RNAi 技术是一种新的癌症治疗方法,目前已有数种候选方法正在接受临床测试。RNAi 在癌症治疗中的显著优势在于其高度特异性,可用于癌症治疗的基因选择无穷无尽。例如,RNAi 疗法可以干扰血管生成、转移、肿瘤化学耐药性和癌细胞增殖。此外,10 种基于 RNAi 的癌症疗法已进入早期临床试验,证明了 RNAi 具有特定基因沉默功效,可用于癌症治疗的潜在能力。因此,上述因素是 2021-2031 年期间 RNAi 疗法市场增长的重要原因。

 

RNAi 治疗市场概览

技术、创新和智能技术解决方案继续对 RNAi 疗法产生重大影响。癌症治疗中的 RNAi 疗法和开发创新 RNAi 疗法的临床试验不断增加是 RNAi 疗法市场增长的最重要因素。不断增加的研发 (R&D) 活动是 RNAi 疗法市场增长的关键趋势。RNAi 疗法的成像模式将提供有利可图的市场机会。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

RNAi 治疗市场:

RNAi Therapeutics Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

RNAi 治疗市场驱动因素和机遇

 

创新 RNAi 疗法临床试验增多,市场前景看好

  • 2023年8月,Sirnaomics宣布“STP707”RNAi疗法进入临床1期,该疗法对转移性肿瘤具有良好的临床潜力。该临床研究在美国进行,多家领先的癌症中心参与,包括梅奥诊所肿瘤科、埃默里癌症中心、南加州大学/霍格分校和耶鲁癌症中心。
  • 此外,Alnylam 公司拥有强大的 RNAi 疗法研发管线,可满足治疗选择有限或不足的患者的需求,这些疾病包括:基因药物、心脏代谢疾病、传染病以及中枢神经系统 (CNS) 和眼部疾病。产品包括“ONPATTRO”、“AMVUTTRA”、“GLVLAARI”、“OXLUMO”、“Leqvio”、“Vutrisiran”、“Fitusiran”、“Cemdisiran”、“Zilebrsiran”、“ALN-HSD”、“Elebsiran”、“Belcesiran”、“ALN-APP”、“ALN-TTRsc04”、“ALN-APP”、“ALN-KHK”、“ALN-BCAT”、“ALN-PNP”。

因此,未来几年 RNAi 疗法的临床试验不断增加将做出重大贡献。

 

RNAi 治疗成像模式为 RNAi 治疗市场带来机遇

目前,多种分子成像模式已应用于 RNAi 相关研究,例如光学成像(荧光和生物发光)、磁共振成像 (MRI)、磁共振波谱 (MRS)、SPECT 和正电子发射断层扫描 (PET)。此外,RNAi 治疗效果的分子成像仍处于临床前阶段,重点是可视化活体动物中的标记基因表达水平。这些成像标记大多是生物发光酶,可以准确测量药理活性。此外,MRS 还被证明可用于评估基于 RNAi 的疗法的疗效,因为它有可能直接检测生物学结果。此外,MRS 在测量某些化合物(例如胆碱)的化学位移方面比光学成像更好,这些化合物在组织或肿瘤中的浓度可以通过某些治疗干预来改变。因此,研发活动提供了有利可图的市场机会,在未来几年为 RNAi 治疗市场占据相当大的市场份额。

 

RNAi 治疗

市场报告细分分析

有助于得出 RNAi 治疗市场分析的关键部分是候选性和服务。

  • 根据分子类型,RNAi 治疗市场分为小干扰 RNA (siRNA) 和微小 RNA (miRNA)。小干扰 RNA (siRNA) 可能在 2023 年占据更大的市场份额。
  • 根据应用,RNAi 治疗市场细分为遗传性疾病、肿瘤学、神经退行性疾病、心血管疾病、呼吸系统疾病、传染病、肾脏疾病等。2023 年,肿瘤学可能会占据更大的市场份额。
  • 根据给药途径,RNAi 治疗市场细分为皮内注射、肺部给药、静脉注射、腹膜内注射等。肺部给药可能在 2023 年占据更大的市场份额。
  • 根据最终用户,RNAi 治疗市场分为诊断实验室、研究和学术实验室以及医院。研究和学术实验室可能在 2023 年占据更大的市场份额。

 

RNAi 治疗市场份额按地区分析

RNAi TherapeuticsMarket报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美/南美和中美。

北美主导着 RNAi 治疗市场。在北美,美国在 RNAi 治疗领域占有相当大的份额。美国拥有顶尖的医疗生物技术和制药公司。此外,合同研究组织 (CRO) 的存在增强了研发 (R&D) 活动,这是推动市场增长的最重要因素之一。预计亚太地区未来几年将以最高的复合年增长率增长。  

 

RNAi 治疗

 

RNAi 治疗市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响 RNAi 治疗市场的区域趋势和因素。本节还讨论了 RNAi 治疗市场在北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的细分市场和地理位置。

RNAi Therapeutics Market
  • 获取 RNAi 治疗市场的区域特定数据

RNAi 治疗市场报告范围

报告属性细节
2021 年市场规模15亿美元
2031 年市场规模32亿美元
全球复合年增长率(2023 - 2031)16.5%
史料2021-2022
预测期2023-2031
涵盖的领域按分子类型
  • 小干扰RNA
  • 微小RNA
按应用
  • 遗传性疾病
  • 肿瘤学
  • 神经退行性疾病
  • 心血管
  • 呼吸系统疾病
  • 传染病
  • 肾脏疾病
按给药途径
  • 皮内注射
  • 肺部给药
  • 静脉注射
  • 腹腔注射
按最终用户
  • 诊断实验室
  • 研究与学术实验室
  • 医院
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Alnylam Pharmaceuticals, Inc.
  • 赛诺菲,
  • Olix Pharmaceuticals, Inc.,
  • 葛兰素史克公司,
  • Benitec Biopharma,
  • Arbutus Biopharma 公司,
  • Silence Therapeutics,
  • Rexahn Pharmaceuticals, Inc.
  • Arrowhead Pharmaceuticals, Inc.,
  • 夸克,

 

RNAi 治疗市场参与者密度:了解其对业务动态的影响

RNAi 治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。

在 RNAi 治疗市场运营的主要公司有:

  1. Alnylam Pharmaceuticals, Inc.
  2. 赛诺菲,
  3. Olix Pharmaceuticals, Inc.,
  4. 葛兰素史克公司,
  5. Benitec Biopharma,
  6. Arbutus Biopharma 公司,

免责声明上面列出的公司没有按照任何特定顺序排列。


RNAi Therapeutics Market

 

  • 获取 RNAi 治疗市场顶级关键参与者概览

 

RNAi 治疗市场新闻和最新发展

RNAi 治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是 RNAi 治疗市场的发展和策略列表:

  • 2024年4月,诺华宣布推出“Leqvio”,在现实环境中作为指南推荐的依折麦布之前的最大耐受性他汀类药物疗法,从而降低动脉粥样硬化性心血管疾病 (ASCVD) 患者的低密度脂蛋白胆固醇 (LDL-C)。

 

RNAi 治疗市场报告覆盖范围和交付成果

“RNAi 治疗市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.